ANDY CHOW: Open Payments
NPI 1336807288 · TEMPLE CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,161 in 53 payments from 11 companies in 2025. Trend: 2023 $937 · 2024 $1,632 · 2025 $1,161
Food & beverage: $1,084Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $468 |
| Madrigal Pharmaceuticals | 4 | $143 |
| Gilead Sciences, Inc. | 8 | $136 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Ardelyx, Inc. | 4 | $97 |
| Janssen Biotech, Inc. | 1 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Aimmune Therapeutics, Inc. | 1 | $27 |
| PFIZER INC. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
Products named: CREON, REZDIFFRA, UZEDY, LINZESS, IBSRELA, TREMFYA, RINVOQ, VIBERZI.
Industry payments across CA — which companies pay providers there.
